NEW YORK (AP) — Pfizer Chairman and CEO Dr. Albert Bourla can now tell the incredible story.
Bourla has a deal with Harper Business for what the publisher is calling “an exclusive, first-hand, behind-the-scenes story” of how the drugmaker managed to develop an effective vaccine against COVID-19 in a remarkably short period of time — months instead of years. Bourla’s “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible” is scheduled to come out Nov. 9.
“I am sharing the story of our moonshot — the challenges we faced, the lessons we learned, and the core values that allowed us to make it happen — in hopes that it might inspire and inform your own moonshot, whatever that may be,” Bourla, 59, said in a statement.
Financial terms were not disclosed. Bourla plans to donate any proceeds to charity.
A native of Greece and descendant of Holocaust survivors, Bourla joined Pfizer in 1993 and rose to CEO in 2018. Pfizer last December became the first U.S. company to have a vaccine authorized by the FDA, which days later approved a vaccine by Moderna and in February one by Johnson & Johnson.
On Monday, the FDA approved the Pfizer vaccine for ages 12-15.
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Entertainment News Click Here
For the latest news and updates, follow us on Google News.